社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Scinai Immunotherapeutics Ltd.(SCNI)
盘后
0.6004
-0.14
-18.53%
19:59 EDT
0.7370
+0.2810
+61.62%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
Scinai Immunotherapeutics Ltd.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.scinai.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Scinai Immunotherapeutics Ltd.于2003年7月22日在以色列成立,是一家私营公司。该公司是一家生物制药公司，专注于开发、制造和商业化创新的炎症和免疫学（I&I）生物产品，主要用于治疗自身免疫和传染病。Scinai拥有先进的生物制药产品开发和制造设施以及经验丰富的制药行业领导地位，提供端到端的精品CDMO服务，同时针对有大量未满足医疗需求的疾病，开发自己的多样化和商业上可行的产品和平台管道。
04-01
年度报告
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-11-12
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-09-30
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-09-22
招股说明书
Form F-1 - Registration statement for certain foreign private issuers
Form F-1 - Registration statement for certain foreign private issuers
2025-05-07
年度报告
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-03-12
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-03-11
[修订]招股说明书
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025-03-04
招股说明书
Form F-1 - Registration statement for certain foreign private issuers
Form F-1 - Registration statement for certain foreign private issuers
2024-11-14
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-08-20
超过5%披露
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024-05-15
年度报告
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024-03-12
超过5%披露
Form SC 13D - General statement of acquisition of beneficial ownership
Form SC 13D - General statement of acquisition of beneficial ownership
2024-02-14
超过5%披露
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024-02-09
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-01-25
超过5%披露
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
分时
5日
日
周
月
数据加载中...
最高
1.05
今开
0.7962
量比
3144.66
最低
0.6567
昨收
0.4560
换手率
6417.46%
热议股票
{"pagemeta":{"title":"Scinai Immunotherapeutics Ltd.(SCNI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Scinai Immunotherapeutics Ltd.(SCNI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Scinai Immunotherapeutics Ltd.,SCNI,Scinai Immunotherapeutics Ltd.股票,Scinai Immunotherapeutics Ltd.股票老虎,Scinai Immunotherapeutics Ltd.股票老虎国际,Scinai Immunotherapeutics Ltd.行情,Scinai Immunotherapeutics Ltd.股票行情,Scinai Immunotherapeutics Ltd.股价,Scinai Immunotherapeutics Ltd.股市,Scinai Immunotherapeutics Ltd.股票价格,Scinai Immunotherapeutics Ltd.股票交易,Scinai Immunotherapeutics Ltd.股票购买,Scinai Immunotherapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scinai Immunotherapeutics Ltd.(SCNI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Scinai Immunotherapeutics Ltd.(SCNI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"SCNI","data":{"stockData":{"symbol":"SCNI","market":"US","secType":"STK","nameCN":"Scinai Immunotherapeutics Ltd.","latestPrice":0.737,"timestamp":1777060800000,"preClose":0.456,"halted":0,"volume":200795853,"hourTrading":{"tag":"盘后","latestPrice":0.6004,"preClose":0.737,"latestTime":"19:59 EDT","volume":2825351,"amount":2006188.288049,"timestamp":1777075199266,"change":-0.1366,"changeRate":-0.185346,"amplitude":0.311533},"delay":0,"changeRate":0.6162280701754385,"floatShares":3128900,"shares":3535488,"eps":-3.557807,"marketStatus":"休市中","change":0.281,"latestTime":"04-24 16:00:00 EDT","open":0.7962,"high":1.05,"low":0.6567,"amount":168994990.4973927,"amplitude":0.8625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.557807,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"adrRate":4000,"listingDate":1431403200000,"exchange":"NASDAQ","adjPreClose":0.456,"preHourTrading":{"tag":"盘前","latestPrice":0.7994,"preClose":0.456,"latestTime":"09:29 EDT","volume":22328428,"amount":18178039.8989452,"timestamp":1777037399878,"change":0.3434,"changeRate":0.75307,"amplitude":1.742105},"postHourTrading":{"tag":"盘后","latestPrice":0.6004,"preClose":0.737,"latestTime":"19:59 EDT","volume":2825351,"amount":2006188.288049,"timestamp":1777075199266,"change":-0.1366,"changeRate":-0.185346,"amplitude":0.311533},"volumeRatio":3144.6640786480707},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20944126","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026038011-SCNI","pdf_url":"","pub_time":1775016000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"SCNI","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/0001213900-26-038011-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea0283609-20f_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0283609-20f_scinai.htm","type":"20-F","id":"NTFILE4eTZGtmY3BuXvHwi","market":"us","size":2377631},{"description":"AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex1-1.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex1-1.htm","type":"EX-1.1","id":"NTFILE38P6x6CfawqH9ZmU","market":"us","size":385914},{"description":"DESCRIPTION OF SHARE CAPITAL","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex2-3.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex2-3.htm","type":"EX-2.3","id":"NTFILE3TM4aT6h9wHAPeJG","market":"us","size":114523},{"description":"LEASE AGREEMENT DATED AUGUST 11, 2020, BETWEEN SCINAI BIOPHARMA AND P L.A.R. MAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex4-16.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex4-16.htm","type":"EX-4.16","id":"NTFILEBHDN9McGKaqvyVhJ","market":"us","size":288500},{"description":"LIST OF SUBSIDIARIES OF THE COMPANY","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex8-1.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex8-1.htm","type":"EX-8.1","id":"NTFILEEF9RBJG5k9GbtWb7","market":"us","size":3756},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex12-1.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex12-1.htm","type":"EX-12.1","id":"NTFILEEdHrMYTRVwF4V3kg","market":"us","size":9321},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex12-2.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex12-2.htm","type":"EX-12.2","id":"NTFILE9coFNYWtdoV1PKrV","market":"us","size":9225},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex13-1.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex13-1.htm","type":"EX-13.1","id":"NTFILEELZ7TgwQu5ezGoJi","market":"us","size":3596},{"description":"CERTIFICATION","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex13-2.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex13-2.htm","type":"EX-13.2","id":"NTFILE5JKwRyXTKZu6fPzg","market":"us","size":3703},{"description":"CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS IN ISRAEL AND A MEMBER OF BDO,","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901ex15-1.htm","primary":false,"translateUrl":"","linkName":"ea028360901ex15-1.htm","type":"EX-15.1","id":"NTFILE4LonL3zf6dQFu5NT","market":"us","size":2527},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_img1.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_img1.jpg","type":"GRAPHIC","id":"NTFILE5FbDqWdGetbpPADu","market":"us","size":2797},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_img2.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_img2.jpg","type":"GRAPHIC","id":"NTFILE22y4GtSKfaGLa1L5","market":"us","size":241916},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_img3.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_img3.jpg","type":"GRAPHIC","id":"NTFILEEMZCm3E1sZ9nX6ME","market":"us","size":241916},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_ex4-16img1.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_ex4-16img1.jpg","type":"GRAPHIC","id":"NTFILE47BSobVwEMxQYPrw","market":"us","size":32184},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_ex4-16img2.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_ex4-16img2.jpg","type":"GRAPHIC","id":"NTFILE2sdaRe1ePS2Q2m5x","market":"us","size":32706},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_ex4-16img3.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_ex4-16img3.jpg","type":"GRAPHIC","id":"NTFILE8nTPfY7QsEmHnZg1","market":"us","size":32136},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_ex4-16img4.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_ex4-16img4.jpg","type":"GRAPHIC","id":"NTFILE7Kuk8v8MFanoyGKa","market":"us","size":75080},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_ex4-16img5.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_ex4-16img5.jpg","type":"GRAPHIC","id":"NTFILEAG1c9Ykdxo2qnBbv","market":"us","size":61923},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026038011/ea028360901_ex4-16img6.jpg","primary":false,"translateUrl":"","linkName":"ea028360901_ex4-16img6.jpg","type":"GRAPHIC","id":"NTFILEEvRuWt5WfNKjXTTi","market":"us","size":108350}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-01 12:00","pubTimestamp":1775016000,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20399456","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025109050-SCNI","pdf_url":"","pub_time":1762923600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"SCNI","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/0001213900-25-109050-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ea0264993-s8_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0264993-s8_scinai.htm","type":"S-8","id":"NTFILE8kKyacQvo9AmNfK8","market":"us","size":84291},{"description":"OPINION OF GOLDFARB GROSS SELIGMAN & CO","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ea026499301ex5-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea026499301ex5-1_scinai.htm","type":"EX-5.1","id":"NTFILEERbKbxpird2db4Ne","market":"us","size":5920},{"description":"CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ea026499301ex23-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea026499301ex23-2_scinai.htm","type":"EX-23.2","id":"NTFILEHsMgtjoL7B22AkUM","market":"us","size":2589},{"description":"CONSENT OF KOST FORER GABBAY AND KASIRER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ea026499301ex23-3_scinai.htm","primary":false,"translateUrl":"","linkName":"ea026499301ex23-3_scinai.htm","type":"EX-23.3","id":"NTFILEAdA46XejPXroyzSm","market":"us","size":2942},{"description":"FILING FEE TABLE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ea026499301ex-fee_scinai.htm","primary":false,"translateUrl":"","linkName":"ea026499301ex-fee_scinai.htm","type":"EX-FILING FEES","id":"NTFILEDLw6bMLir38keAme","market":"us","size":13051},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE3rRtShQqntAU5XMR","market":"us","size":12071},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025109050/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEFS3eqVpBZqGyDwBi","market":"us","size":40777}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2025-11-12 13:00","pubTimestamp":1762923600,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20672868","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025093118-SCNI","pdf_url":"","pub_time":1759177836000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"SCNI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/0001213900-25-093118-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025093118/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE3s51qAYAGNZpBy1k","market":"us","size":5174}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-09-30 04:30","pubTimestamp":1759177836,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20193389","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025089916-SCNI","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"SCNI","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/0001213900-25-089916-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ea0258179-f1_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0258179-f1_scinai.htm","type":"F-1","id":"NTFILEDKScC7gjUGLRcUuq","market":"us","size":437564},{"description":"OPINION OF GOLDFARB GROSS SELIGMAN & CO","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ea025817901ex5-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea025817901ex5-1_scinai.htm","type":"EX-5.1","id":"NTFILE2dyyYZyMZBrNzcXL","market":"us","size":10366},{"description":"CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ea025817901ex23-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea025817901ex23-1_scinai.htm","type":"EX-23.1","id":"NTFILEEqJHMkfL5F7hkRwk","market":"us","size":3725},{"description":"CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ea025817901ex23-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea025817901ex23-2_scinai.htm","type":"EX-23.2","id":"NTFILE5b5Eo33neyBFCjbp","market":"us","size":2502},{"description":"FILING FEE TABLE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ea025817901ex-fee_scinai.htm","primary":false,"translateUrl":"","linkName":"ea025817901ex-fee_scinai.htm","type":"EX-FILING FEES","id":"NTFILE22rBpuUfJxddQLsg","market":"us","size":14555},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE527bU9bwMWYY2kXG","market":"us","size":15707},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEJ6Fxa2XLevYgVv6t","market":"us","size":3722},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE7F31KZ9uni1wyWjv","market":"us","size":12872},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ex23-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex23-1_001.jpg","type":"GRAPHIC","id":"NTFILEVrQc1bev7t6uvZsf","market":"us","size":5314},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025089916/ex23-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex23-1_002.jpg","type":"GRAPHIC","id":"NTFILEHnNUnFtoxPzJpptu","market":"us","size":10697}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19610074","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025040402-SCNI","pdf_url":"","pub_time":1746590400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"SCNI","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/0001213900-25-040402-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea0239669-20f_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0239669-20f_scinai.htm","type":"20-F","id":"NTFILECpitwhFGZKYGcrGg","market":"us","size":1962887},{"description":"ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex1-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex1-1_scinai.htm","type":"EX-1.1","id":"NTFILESnDmovw8rq1NSXqM","market":"us","size":355548},{"description":"DESCRIPTION OF SHARE CAPITAL","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex2-3_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex2-3_scinai.htm","type":"EX-2.3","id":"NTFILEDYKycsd5hRDVSpmY","market":"us","size":114401},{"description":"COMPENSATION POLICY","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-3_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-3_scinai.htm","type":"EX-4.3","id":"NTFILEAvvoPjSSyAkPqHrC","market":"us","size":120813},{"description":"AMENDMENT NO. 1 TO LEASE AGREEMENT, DATED APRIL 29, 2022 (UNOFFICIAL TRANSLATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-15_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-15_scinai.htm","type":"EX-4.15","id":"NTFILEnRBvz9AnM6GoxgDu","market":"us","size":22480},{"description":"AMENDMENT NO. 2 TO LEASE AGREEMENT, DATED JUNE 3, 2023 (UNOFFICIAL TRANSLATION F","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-16_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-16_scinai.htm","type":"EX-4.16","id":"NTFILE6EfHeepovwZsxksw","market":"us","size":21240},{"description":"AMENDMENT NO. 3 TO LEASE AGREEMENT, DATED JULY 10, 2023 (UNOFFICIAL TRANSLATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-17_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-17_scinai.htm","type":"EX-4.17","id":"NTFILEF6YczVTcpd48GBm9","market":"us","size":17834},{"description":"AMENDMENT NO. 4 TO LEASE AGREEMENT, DATED DECEMBER 15, 2024 (UNOFFICIAL TRANSLAT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-18_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-18_scinai.htm","type":"EX-4.18","id":"NTFILE9SYdyXdKZhfYTwXT","market":"us","size":18606},{"description":"AMENDMENT NO. 5 TO LEASE AGREEMENT, DATED DECEMBER 24, 2024. (UNOFFICIAL TRANSLA","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-19_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-19_scinai.htm","type":"EX-4.19","id":"NTFILE2tUoQacwPcrBYaqq","market":"us","size":15840},{"description":"BINDING OPTION AGREEMENT CONCERNING THE SALE AND TRANSFER OF ALL QUOTA IN PINCEL","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex4-29_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex4-29_scinai.htm","type":"EX-4.29","id":"NTFILEDrpcAEpDzxdrPKWt","market":"us","size":467361},{"description":"LIST OF SUBSIDIARIES OF THE COMPANY","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex8-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex8-1_scinai.htm","type":"EX-8.1","id":"NTFILEAc9UMfMkxa6PGvzH","market":"us","size":2836},{"description":"INSIDER TRADING POLICY","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex11-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex11-2_scinai.htm","type":"EX-11.2","id":"NTFILE3bdVGMhArVZsUSeU","market":"us","size":63425},{"description":"CERTIFICATION","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex12-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex12-1_scinai.htm","type":"EX-12.1","id":"NTFILE2fYrbQBKNksrCq8q","market":"us","size":9242},{"description":"CERTIFICATION","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex12-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex12-2_scinai.htm","type":"EX-12.2","id":"NTFILEGbvE7EEwFdUq3kHW","market":"us","size":9073},{"description":"CERTIFICATION","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex13-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex13-1_scinai.htm","type":"EX-13.1","id":"NTFILEMVy56nuCmgbN47RW","market":"us","size":3483},{"description":"CERTIFICATION","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex13-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex13-2_scinai.htm","type":"EX-13.2","id":"NTFILE28EDxF3UyD4NMLsc","market":"us","size":3464},{"description":"CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER F","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex15-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex15-1_scinai.htm","type":"EX-15.1","id":"NTFILE9X7rg27Wpvas7piy","market":"us","size":2305},{"description":"CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ea023966901ex15-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023966901ex15-2_scinai.htm","type":"EX-15.2","id":"NTFILEHA1AA9vFMMFsNHaW","market":"us","size":2738},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/fin_001.jpg","primary":false,"translateUrl":"","linkName":"fin_001.jpg","type":"GRAPHIC","id":"NTFILE2dn457x1GVRLgjKC","market":"us","size":6238},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/fin_002.jpg","primary":false,"translateUrl":"","linkName":"fin_002.jpg","type":"GRAPHIC","id":"NTFILEBvRCLwhpDbsAPeHx","market":"us","size":2620},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/fin_003.jpg","primary":false,"translateUrl":"","linkName":"fin_003.jpg","type":"GRAPHIC","id":"NTFILEDXbpZxX9jsgXcL6u","market":"us","size":5446},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025040402/ex4-24_001.jpg","primary":false,"translateUrl":"","linkName":"ex4-24_001.jpg","type":"GRAPHIC","id":"NTFILEAFL87bBDVP47YT4V","market":"us","size":2506}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-05-07 12:00","pubTimestamp":1746590400,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19370854","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025022696-SCNI","pdf_url":"","pub_time":1741719735000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"SCNI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/0001213900-25-022696-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022696/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE7hXjwfvq2PbwV1aN","market":"us","size":6303}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-03-12 03:02","pubTimestamp":1741719735,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19226394","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025022648-SCNI","pdf_url":"","pub_time":1741665600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","symbol":"SCNI","title":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/0001213900-25-022648-index.htm","us_notice_code":"Form F-1/A","us_title_en":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/ea0233973-f1a1_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0233973-f1a1_scinai.htm","type":"F-1/A","id":"NTFILE5dd4iwG7ugYAunsT","market":"us","size":2322026},{"description":"CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/ea023397301ex23-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023397301ex23-1_scinai.htm","type":"EX-23.1","id":"NTFILEEv28mAJgUsBmLkHh","market":"us","size":4305},{"description":"CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/ea023397301ex23-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023397301ex23-2_scinai.htm","type":"EX-23.2","id":"NTFILE9ueXgpfpBoyg6nJ3","market":"us","size":2838},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEEDXuHzN3eRwek2ff","market":"us","size":5359},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE4UkgpEeNXMVZabkh","market":"us","size":1968},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/image_003.jpg","primary":false,"translateUrl":"","linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILEA2PVmQWkbnWZamvT","market":"us","size":1954},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/image_004.jpg","primary":false,"translateUrl":"","linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILEEbSapL1EMrxayzDB","market":"us","size":10641},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/ex23-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex23-1_001.jpg","type":"GRAPHIC","id":"NTFILE6wBPqRUskxcgjBxw","market":"us","size":6513},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025022648/ex23-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex23-1_002.jpg","type":"GRAPHIC","id":"NTFILEBjkFGJ9H2ZMAKJLj","market":"us","size":10697}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-03-11 12:00","pubTimestamp":1741665600,"title_zh":"Form F-1/A - Registration statement for certain foreign private issuers: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19201513","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025020296-SCNI","pdf_url":"","pub_time":1741064400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form F-1 - Registration statement for certain foreign private issuers","symbol":"SCNI","title":"Form F-1 - Registration statement for certain foreign private issuers","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/0001213900-25-020296-index.htm","us_notice_code":"Form F-1","us_title_en":"Form F-1 - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea0232392-f1_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0232392-f1_scinai.htm","type":"F-1","id":"NTFILEEwoA7Y9F8UgSpMuX","market":"us","size":2308700},{"description":"ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex3-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex3-1_scinai.htm","type":"EX-3.1","id":"NTFILE7rmw8qWEx1T9YTT1","market":"us","size":364401},{"description":"OPINION OF GOLDFARB GROSS SELIGMAN & CO","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex5-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex5-1_scinai.htm","type":"EX-5.1","id":"NTFILEFSauX3Zmf11oRakz","market":"us","size":11080},{"description":"LOAN RESTRUCTURING AGREEMENT, DATED AUGUST 9, 2024, BETWEEN THE COMPANY AND THE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex10-12_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex10-12_scinai.htm","type":"EX-10.12","id":"NTFILE73h2dnu4y5L4eirJ","market":"us","size":514364},{"description":"INVESTMENT AGREEMENT, BETWEEN THE COMPANY AND RK STONE MIAMI, LLC, DATED AS OF A","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex10-21_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex10-21_scinai.htm","type":"EX-10.21","id":"NTFILE53Yg4sgd1BctGpbp","market":"us","size":101740},{"description":"FORM OF WARRANT ISSUED IN CONNECTION WITH THE STONE INVESTMENT AGREEMENT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex10-22_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex10-22_scinai.htm","type":"EX-10.22","id":"NTFILE8e1AbqG6HtzVSxCJ","market":"us","size":100509},{"description":"LIST OF SUBSIDIARIES OF THE COMPANY","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex21-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex21-1_scinai.htm","type":"EX-21.1","id":"NTFILE8gXV5tpkrZo9KRqQ","market":"us","size":2108},{"description":"CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex23-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex23-1_scinai.htm","type":"EX-23.1","id":"NTFILE27gopuZdUeu9pQ4r","market":"us","size":4333},{"description":"CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex23-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex23-2_scinai.htm","type":"EX-23.2","id":"NTFILE9NNGwMmzg6WtzCRF","market":"us","size":4413},{"description":"FILING FEE TABLE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ea023239201ex-fee_scinai.htm","primary":false,"translateUrl":"","linkName":"ea023239201ex-fee_scinai.htm","type":"EX-FILING FEES","id":"NTFILEGUKrqCkCvwzTUm6d","market":"us","size":19475},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE7wBoN2oZNzcWNgUt","market":"us","size":5359},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE4GBdK9GS1j5CMxGh","market":"us","size":1968},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/image_004.jpg","primary":false,"translateUrl":"","linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILE5k5VTpH3aK5mGukS","market":"us","size":10641},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/image_003.jpg","primary":false,"translateUrl":"","linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILEFg7ET818TCuAKqia","market":"us","size":1954},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEHuWsGoTPrVUhxQVN","market":"us","size":11807},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE77oF4hgtoH4KVjmM","market":"us","size":38855},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ex10-12_001.jpg","primary":false,"translateUrl":"","linkName":"ex10-12_001.jpg","type":"GRAPHIC","id":"NTFILEG1KcuoT8BzMiFzfn","market":"us","size":1980},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ex23-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex23-1_001.jpg","type":"GRAPHIC","id":"NTFILEGrxRai1wqVDuZ7o3","market":"us","size":6513},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ex23-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex23-1_002.jpg","type":"GRAPHIC","id":"NTFILE65Bn1pQSagDL7eaZ","market":"us","size":10697},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390025020296/ex23-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex23-2_001.jpg","type":"GRAPHIC","id":"NTFILE2x35MW1yu6Vp8pSw","market":"us","size":2277}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-03-04 13:00","pubTimestamp":1741064400,"title_zh":"Form F-1 - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18835428","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266124005250-SCNI","pdf_url":"","pub_time":1731560400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"SCNI","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/000117266124005250/0001172661-24-005250-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1601086/000117266124005250/armistice-scni093024a1.htm","primary":true,"translateUrl":"","linkName":"armistice-scni093024a1.htm","type":"SC 13G/A","id":"NTFILEGfGMyMLXfWQDtYyA","market":"us","size":89127}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-11-14 13:00","pubTimestamp":1731560400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18494668","market":"us","labels":[],"media":"sec.gov","original_id":"AN91228224000580-SCNI","pdf_url":"","pub_time":1724126400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"SCNI","title":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000580/0000912282-24-000580-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT 3 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000580/13g.htm","primary":true,"translateUrl":"","linkName":"13g.htm","type":"SC 13G/A","id":"NTFILE6FxXQB2ePQwEGxQo","market":"us","size":34825}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-08-20 12:00","pubTimestamp":1724126400,"title_zh":"Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18148603","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024043560-SCNI","pdf_url":"","pub_time":1715745600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"SCNI","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/0001213900-24-043560-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea0205908-20f_scinai.htm","primary":true,"translateUrl":"","linkName":"ea0205908-20f_scinai.htm","type":"20-F","id":"NTFILEA1NucR3Y5LYce2Hb","market":"us","size":1881441},{"description":"DESCRIPTION OF SHARE CAPITAL","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex2-3_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex2-3_scinai.htm","type":"EX-2.3","id":"NTFILED3qvSGzcDSbbhgRP","market":"us","size":114363},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex12-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex12-1_scinai.htm","type":"EX-12.1","id":"NTFILE611tCku3ANAPtA3V","market":"us","size":10521},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex12-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex12-2_scinai.htm","type":"EX-12.2","id":"NTFILEHgZ95DAv7pNfgCYE","market":"us","size":10348},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex13-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex13-1_scinai.htm","type":"EX-13.1","id":"NTFILEATRwyrc7p4YzEtCZ","market":"us","size":4041},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex13-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex13-2_scinai.htm","type":"EX-13.2","id":"NTFILEH2dUgDnDyLG1ENGu","market":"us","size":3999},{"description":"CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER F","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex15-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex15-1_scinai.htm","type":"EX-15.1","id":"NTFILE5SWsrkS1NaYC1qcu","market":"us","size":3817},{"description":"CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex15-2_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex15-2_scinai.htm","type":"EX-15.2","id":"NTFILEBsy58XsogNJdg9i3","market":"us","size":2701},{"description":"LETTER, FROM KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex16-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex16-1_scinai.htm","type":"EX-16.1","id":"NTFILEC5M8prZvUQWbfGFx","market":"us","size":3290},{"description":"SCINAI IMMUNOTHERAPEUTICS POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATIO","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ea020590801ex97-1_scinai.htm","primary":false,"translateUrl":"","linkName":"ea020590801ex97-1_scinai.htm","type":"EX-97.1","id":"NTFILE8PEoq6Ne7rWBgmJ9","market":"us","size":31227},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEBVz9MGYKPWjRKZ8o","market":"us","size":6121},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILECv8Cr7pxaPyX1m4t","market":"us","size":2265},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/image_003.jpg","primary":false,"translateUrl":"","linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILEFz6AsfFbXeKpL7h1","market":"us","size":2620},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ex15-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex15-1_001.jpg","type":"GRAPHIC","id":"NTFILEnsGrt3qCwe1ucxnc","market":"us","size":5516},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024043560/ex15-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex15-1_002.jpg","type":"GRAPHIC","id":"NTFILE3GZ2Ccmw4ttWcMnj","market":"us","size":2620}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2024-05-15 12:00","pubTimestamp":1715745600,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17698021","market":"us","labels":[],"media":"sec.gov","original_id":"AN91228224000243-SCNI","pdf_url":"","pub_time":1710216000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General statement of acquisition of beneficial ownership","symbol":"SCNI","title":"Form SC 13D - General statement of acquisition of beneficial ownership","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000243/0000912282-24-000243-index.htm","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000243/sc13d.htm","primary":true,"translateUrl":"","linkName":"sc13d.htm","type":"SC 13D","id":"NTFILECe7LegDf96jBHC5S","market":"us","size":39533},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000243/image0.jpg","primary":false,"translateUrl":"","linkName":"image0.jpg","type":"GRAPHIC","id":"NTFILEBPHnvM5kzze43n22","market":"us","size":2979}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-03-12 12:00","pubTimestamp":1710216000,"title_zh":"Form SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17598676","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266124001405-SCNI","pdf_url":"","pub_time":1707886800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SCNI","title":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/000117266124001405/0001172661-24-001405-index.htm","us_notice_code":"Form SC 13G","us_title_en":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1601086/000117266124001405/armistice-scni123123.htm","primary":true,"translateUrl":"","linkName":"armistice-scni123123.htm","type":"SC 13G","id":"NTFILEEhSZwVszkCtJM27T","market":"us","size":89087}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-02-14 13:00","pubTimestamp":1707886800,"title_zh":"Form SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17704149","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024011800-SCNI","pdf_url":"","pub_time":1707480002000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"SCNI","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/0001213900-24-011800-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000121390024011800/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE3JpHWbH9Y1oGFdTs","market":"us","size":12756}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-02-09 20:00","pubTimestamp":1707480002,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17508680","market":"us","labels":[],"media":"sec.gov","original_id":"AN91228224000070-SCNI","pdf_url":"","pub_time":1706124839000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","symbol":"SCNI","title":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000070/0000912282-24-000070-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"AMENDMENT NO. 2 TO SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611747/000091228224000070/sc13a2.htm","primary":true,"translateUrl":"","linkName":"sc13a2.htm","type":"SC 13G/A","id":"NTFILE88hF8hvk3ReDMGBV","market":"us","size":34302}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-01-25 03:33","pubTimestamp":1706124839,"title_zh":"Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.scinai.com","stockEarnings":[{"period":"1week","weight":0.3279},{"period":"1month","weight":0.1},{"period":"3month","weight":-0.2626},{"period":"6month","weight":-0.4952},{"period":"1year","weight":-0.6955},{"period":"ytd","weight":0.035}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scinai Immunotherapeutics Ltd.于2003年7月22日在以色列成立,是一家私营公司。该公司是一家生物制药公司，专注于开发、制造和商业化创新的炎症和免疫学（I&I）生物产品，主要用于治疗自身免疫和传染病。Scinai拥有先进的生物制药产品开发和制造设施以及经验丰富的制药行业领导地位，提供端到端的精品CDMO服务，同时针对有大量未满足医疗需求的疾病，开发自己的多样化和商业上可行的产品和平台管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.123027},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.04681},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.045692},{"month":4,"riseRate":0.545455,"avgChangeRate":0.094904},{"month":5,"riseRate":0.5,"avgChangeRate":0.025358},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.041702},{"month":7,"riseRate":0.545455,"avgChangeRate":0.067743},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.046786},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.108328},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.094214},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.010725},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.063466}],"exchange":"NASDAQ","name":"Scinai Immunotherapeutics Ltd.","nameEN":"Scinai Immunotherapeutics Ltd."},"aProfile":null}}}